CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Mar. 31, 2024	$ 1	$ 15,201	$ (7,399)	$ 7,803
Balance (in shares) at Mar. 31, 2024	8,777,432
Stock issued for termination fee		1,536		1,536
Stock issued for termination fee (in shares)	320,000
Stock-based compensation		9		9
Net Income (Loss)			(1,460)	(1,460)
Balance at Jun. 30, 2024	$ 1	16,746	(8,859)	7,888
Balance (in shares) at Jun. 30, 2024	9,097,432
Sale of stock and warrants, net		1,588		1,588
Sale of stock and warrants, net (in shares)	521,800
Stock-based compensation		9		9
Net Income (Loss)			(601)	(601)
Balance at Sep. 30, 2024	$ 1	18,343	(9,460)	8,884
Balance (in shares) at Sep. 30, 2024	9,619,232
Restricted stock awards (in shares)	45,000
Stock-based compensation		22		22
Stock used for tax withholding		(6)		(6)
Stock used for tax withholding (in shares)	(1,707)
Net Income (Loss)			(799)	(799)
Balance at Dec. 31, 2024	$ 1	18,359	(10,259)	8,101
Balance (in shares) at Dec. 31, 2024	9,662,525
Balance at Mar. 31, 2025	$ 1	18,885	(10,146)	8,740
Balance (in shares) at Mar. 31, 2025	9,761,825
Stock issued for exercised options (in shares)	15,711
Stock-based compensation		69		69
Net Income (Loss)			(597)	(597)
Balance at Jun. 30, 2025	$ 1	18,954	(10,743)	8,212
Balance (in shares) at Jun. 30, 2025	9,777,536
Stock issued for exercised options (in shares)	175,414
Stock-based compensation		70		70
Net Income (Loss)			825	825
Balance at Sep. 30, 2025	$ 1	19,024	(9,918)	9,107
Balance (in shares) at Sep. 30, 2025	9,952,950
Restricted stock awards		314		314
Restricted stock awards (in shares)	60,000
Stock-based compensation		69		69
Stock used for tax withholding		(38)		(38)
Stock used for tax withholding (in shares)	(1,618)
Net Income (Loss)			(1,473)	(1,473)
Balance at Dec. 31, 2025	$ 1	$ 19,369	$ (11,391)	$ 7,979
Balance (in shares) at Dec. 31, 2025	10,011,332